Keros Therapeutics Inc. (KROS)
NASDAQ: KROS
· Real-Time Price · USD
14.41
0.45 (3.22%)
At close: Aug 14, 2025, 3:59 PM
14.42
0.07%
Pre-market: Aug 15, 2025, 08:45 AM EDT
Keros Therapeutics Revenue
Keros Therapeutics reported an annual revenue of $3.55M, reflecting a 2250.99% growth. For the quarter ending June 30, 2025, Keros Therapeutics generated $18.17M in revenue.
Revenue (ttm)
3.55M
Revenue Growth
2250.99%
Price / Sales Ratio
166.94
Revenue / Employee
21.78K
Employees
163
Market Cap
585.27M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|